EU
OMass Therapeutics
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics for rare diseases and immunological conditions using its OdyssION platform.
omass.com
1
offres actives
Voir toutes les offres de l'entreprise
Hybride 1
À propos de l'entreprise
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics. Its work focuses on rare diseases and immunological conditions, with programmes aimed at targets such as membrane proteins, intracellular complexes, solute carriers and GPCRs. The company describes its OdyssION platform as combining novel biochemistry, native mass spectrometry and custom chemistry.
Points utiles aux candidats
- Biotechnology company developing small-molecule therapeutics.
- Focuses on rare diseases and immunological conditions.
- Uses the OdyssION technology platform for drug discovery.
- Secteur économique
- Biotechnology
- Orientation commerciale
- Drug discovery and development of small-molecule therapeutics
- Siège
- Oxford
Offres en cours
1
offres actives
- Principales villes
- Oxford (1)
- Mode de travail
- Hybride (1)
- Contrat
- Temps plein (1)